- Novo Nordisk wins 3,071 prescriptions for Wegovy pill (NVO:NYSE) Seeking Alpha
- Novo Nordisk shares rise 5% after Wegovy obesity pill has ‘solid’ launch CNBC
- Lubbock Doctor compares weight loss injections to new pills KCBD
- Novo Nordisk’s Wegovy Weight Loss Pill Has a Strong Launch—and Other Reasons the Stock Is Rising Barron’s
- Novo Nordisk sees pills capturing over third of GLP-1 obesity market by 2030 Reuters
